Adaptive Biotechnologies Corporation
ADPT
$9.29
-$0.22-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.85M | -33.69M | -32.07M | -46.22M | -47.51M |
| Total Depreciation and Amortization | 4.73M | 4.45M | 4.59M | 5.00M | 5.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.78M | 13.70M | 13.44M | 21.09M | 14.25M |
| Change in Net Operating Assets | -16.14M | 3.05M | -13.03M | 2.83M | -10.31M |
| Cash from Operations | -28.48M | -12.49M | -27.07M | -17.30M | -38.35M |
| Capital Expenditure | -1.26M | -80.00K | -344.00K | -1.73M | -1.51M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.83M | 22.20M | 5.63M | 7.61M | 46.02M |
| Cash from Investing | 25.57M | 22.12M | 5.29M | 5.88M | 44.51M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.45M | 127.00K | 40.00K | 30.00K | 44.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.45M | 127.00K | 40.00K | 30.00K | 44.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.54M | 9.76M | -21.74M | -11.40M | 6.20M |